Current view on ductal carcinoma in situ and importance of the margin thresholds: A review

por Van Cleef, A., Altintas, S., Huizing, M., Papadimitriou, K., Van Dam, P., Tjalma, W.
Publicado 2014

The socio-economical impact of intravenous (IV) versus subcutaneous (SC) administration of trastuzumab: future prospectives

por Papadmitriou, K., Trinh, X.B., Altintas, S., Van Dam, P.A., Huizing, M.T., Tjalma, W.A.A.
Publicado 2015

Cremophor EL causes (pseudo-) non-linear pharmacokinetics of paclitaxel in patients

por Tellingen, O van, Huizing, M T, Panday, V R Nannan, Schellens, J H M, Nooijen, W J, Beijnen, J H
Publicado 1999

Benchmarking and audit of breast units improves quality of care

por van Dam, P.A., Verkinderen, L., Hauspy, J., Vermeulen, P., Dirix, L., Huizing, M., Altintas, S., Papadimitriou, K., Peeters, M., Tjalma, W.
Publicado 2013

36P Alterations in tumour-promoting cytokines in cancer patients after SARS-CoV-2 infection

por De Winter, F.H., Hotterbeekx, A., Huizing, M., Konnova, A., Jongers, B. 's, Jairam, R.K., Moons, P., Roelant, E., Le Blon, D., Vanden Berghe, W., Janssens, A., Lybaert, W., Croes, L., Vulsteke, C., Malhotra-Kumar, S., Goossens, H., Berneman, Z., Peeters, M., Van Dam, P., Kumar-Singh, S.
Publicado 2021

Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment

por Peeters, M., Verbruggen, L., Teuwen, L., Vanhoutte, G., Vande Kerckhove, S., Peeters, B., Raats, S., Van der Massen, I., De Keersmaecker, S., Debie, Y., Huizing, M., Pannus, P., Neven, K., Ariën, K.K., Martens, G.A., Van Den Bulcke, M., Roelant, E., Desombere, I., Anguille, S., Goossens, M., Vandamme, T., van Dam, P.
Publicado 2021